Rivipansel
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Rivipansel, covering 2018-11-28 to 2025-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease [Phase 3]